PROVECTUS BIOPHARMACEUTICALS, INC. - PVCT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | CEO | A | A | 45,860.0 | 0.0 | 0.0 | 2,866,761.0 | View | |
| Jun 30, 2026 | PRESIDENT | A | A | 45,860.0 | 0.0 | 0.0 | 1,383,736.0 | View | |
| Jun 30, 2026 | — | A | A | 48,917.0 | 0.0 | 0.0 | 228,509.0 | View | |
| Jun 30, 2026 | — | A | A | 48,917.0 | 0.0 | 0.0 | 207,535.0 | View | |
| Jun 05, 2026 | CEO | M | A | 9,436.0 | 0.0 | 0.0 | 2,857,285.0 | View | |
| Jun 05, 2026 | CEO | M | D | — | 0.0 | — | — | View | |
| May 29, 2026 | CEO | A | A | — | 0.0 | — | — | View | |
| May 26, 2026 | CEO | M | A | 32,089.0 | 0.0 | 0.0 | 2,847,849.0 | View | |
| May 26, 2026 | CEO | M | D | — | 0.0 | — | — | View | |
| May 15, 2026 | CEO | M | A | 22,651.0 | 0.0 | 0.0 | 2,815,760.0 | View | |
| May 15, 2026 | CEO | M | D | — | 0.0 | — | — | View | |
| May 07, 2026 | CEO | M | A | 18,876.0 | 0.0 | 0.0 | 2,793,109.0 | View | |
| May 07, 2026 | CEO | M | D | — | 0.0 | — | — | View | |
| Apr 29, 2026 | CEO | M | A | 30,202.0 | 0.0 | 0.0 | 2,774,233.0 | View | |
| Apr 29, 2026 | CEO | M | D | — | 0.0 | — | — | View |